← Azimuth Daily
Capturing data…
Capturing data…
TUE, 3 NOV · 81 ITEMS
"DSM to include biological markers, psychiatrist explains implications" — Live Science · Science & Medicine
The — the American Psychiatric Association's Diagnostic and Statistical Manual of Mental Disorders, the book that defines how mental illnesses are diagnosed in the US and much of the world — has always been a checklist of symptoms. The APA now says the next edition will, for the first time, fold in biology: genetics, blood-based markers, brain imaging and other biological measures, alongside the symptom criteria. This Live Science piece is a first-person explainer by a psychiatrist who sits on the team writing that next edition, walking through what adding biology would and wouldn't change. The important qualifier is that this is a multi-year roadmap, not a shipped product: outside of the Alzheimer's-associated proteins, psychiatry still has no validated diagnostic biomarker for conditions like depression or schizophrenia.
The claim tracks a named primary source closely — the APA's January 2026 'roadmap for the future of the DSM' release and its four accompanying papers, one of which is specifically on the role of
Current as a Live Science publication (November 2, 2026), but the piece is a republication of an essay that first ran in The Conversation in late August 2026, so the argument itself is a few months old rather than breaking.